MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$25,982K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities and red...
Decrease in prepaid expenses and...
Share-based compensation net of ...
Others
Negative Cash Flow Breakdown
Increase in accounts receivable,...
Interest expense accrued on liab...
Payments of liabilities related ...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Net loss
-39,111
125,598
-197,196
-
Depreciation on property and equipment
2,161
-3,945
2,079
4,075
Amortization of right-of-use assets
-
-
825
1,943
Amortization of intangible assets
489
-539
459
570
Inventory reserves and write-offs
1,054
-5,533
4,335
3,244
Loss on disposal of property and equipment
0
1
0
-3
Share-based compensation net of amounts capitalized
4,595
-7,430
3,835
7,160
Interest expense accrued on liabilities related to future royalties and milestones, net
-2,724
-2,757
10,493
3,294
Accretion of available-for-sale securities
-292
5,858
-1,690
-5,103
Foreign exchange differences
108
-5,994
-3,219
5,702
Loss on termination of operating lease
-
-
0
-
Non-cash operating lease expense
881
883
-
-
Impairment of operating lease right-of-use assets and related property and equipment
293
-
0
-
Deferred income tax
-788
900
-13
-871
Decrease in prepaid expenses and other current assets
-22,383
-11,227
18,573
-5,452
Decrease (increase) in prepaid expenses and other non-current assets
-30
-165
-4,588
4,701
Increase in inventories, net
1,193
-27,599
8,602
21,538
Increase in accounts receivable, net
16,743
-29,095
6,001
26,726
(decrease) increase in accounts payable
-667
-9,989
5,421
3,395
Increase in deferred revenue
0
-7,612
5,512
2,100
Decrease in accrued expenses and other liabilities
1,958
-4,983
2,710
-5,237
Increase in operating lease liability
1,137
-9,034
2,593
6,635
Net cash used in operating activities
-25,069
150,928
-67,899
-148,346
Acquisition of property and equipment
913
-17,240
4,408
15,520
Acquisition of intangibles assets
-
-
8,089
-
Purchases of marketable securities available-for-sale debt securities
0
-187,517
82,939
119,299
Proceeds from maturities and redemptions of marketable securities available-for-sale debt securities
68,813
-188,610
130,983
171,187
Net cash provided by investing activities
67,900
24,236
35,547
36,368
Proceeds of issuance of ordinary shares
-
-
0
0
Payments of equity issuance costs
-
-
0
0
Proceeds from the exercise of share options
3
-
0
0
Proceeds from liabilities related to future royalties and milestones, net
-
-
0
0
Payments of issuance costs related to the liabilities related to future royalties and milestones, net
-
-
0
0
Payments of liabilities related to future royalties and milestones, net
2,144
-480
1,774
768
Net cash used in financing activities
-2,141
480
-1,774
-768
Effect of exchange rate changes on cash, cash equivalents and restricted cash
-199
-7,679
-3,583
9,273
Net increase (decrease) in cash, cash equivalents and restricted cash
40,491
167,965
-37,709
-103,473
Cash, cash equivalents and restricted cash, beginning of period
87,622
87,622
228,804
-
Cash, cash equivalents and restricted cash, end of period
172,910
-
-
-
Cash paid for income taxes
1,307
-
-
-
Property and equipment purchases included in accounts payable or accrued expenses
158
-
-
-
Leased assets obtained in exchange for operating lease liabilities
11,654
-
-
-
Capitalized implementation costs included in accounts payable and accrued expenses
209
-
-
-
Cash and cash equivalents
171,414
-
-
-
Restricted cash
1,496
-
-
-
Total cash, cash equivalents and restricted cash
172,910
132,418
87,622
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
and redemptions of...
$68,813K
(-59.80%↓ Y/Y)
Net cash provided by
investing activities
$67,900K
(86.70%↑ Y/Y)
Canceled cashflow
$913K
Net increase
(decrease) in cash, cash...
$40,491K
(139.13%↑ Y/Y)
Canceled cashflow
$27,409K
Acquisition of property and
equipment
$913K
(-94.12%↓ Y/Y)
Decrease in prepaid
expenses and other...
-$22,383K
(-310.55%↓ Y/Y)
Share-based compensation
net of amounts...
$4,595K
(-35.82%↓ Y/Y)
Depreciation on property and
equipment
$2,161K
(-46.97%↓ Y/Y)
Decrease in accrued
expenses and other...
$1,958K
(137.39%↑ Y/Y)
Increase in operating
lease liability
$1,137K
(-82.86%↓ Y/Y)
Inventory reserves and
write-offs
$1,054K
(-67.51%↓ Y/Y)
Non-cash operating lease
expense
$881K
Deferred income tax
-$788K
(9.53%↑ Y/Y)
Amortization of intangible
assets
$489K
(-14.21%↓ Y/Y)
Impairment of operating
lease right-of-use...
$293K
Decrease (increase) in
prepaid expenses and...
-$30K
(-100.64%↓ Y/Y)
Proceeds from the
exercise of share options
$3K
Net cash used in
operating activities
-$25,069K
(83.10%↑ Y/Y)
Net cash used in
financing activities
-$2,141K
(-178.78%↓ Y/Y)
Effect of exchange rate
changes on cash, cash...
-$199K
(-102.15%↓ Y/Y)
Canceled cashflow
$35,769K
Canceled cashflow
$3K
Net loss
-$39,111K
Payments of liabilities
related to future...
$2,144K
(179.17%↑ Y/Y)
Increase in accounts
receivable, net
$16,743K
(-37.35%↓ Y/Y)
Interest expense accrued
on liabilities...
-$2,724K
(-182.70%↓ Y/Y)
Increase in inventories,
net
$1,193K
(-94.46%↓ Y/Y)
(decrease) increase in
accounts payable
-$667K
(-119.65%↓ Y/Y)
Accretion of
available-for-sale securities
-$292K
(94.28%↑ Y/Y)
Foreign exchange
differences
$108K
(-98.11%↓ Y/Y)
Buy us a coffee
Autolus Therapeutics plc (AUTL)
Autolus Therapeutics plc (AUTL)